Drug-drug interaction and initial dosage optimization of aripiprazole in patients with schizophrenia based on population pharmacokinetics.

MLA

Cun Zhang, et al. “Drug-Drug Interaction and Initial Dosage Optimization of Aripiprazole in Patients with Schizophrenia Based on Population Pharmacokinetics.” Frontiers in Psychiatry, July 2024, pp. 1–10. EBSCOhost, https://doi.org/10.3389/fpsyt.2024.1377268.

APA

Cun Zhang, Lei Jiang, Ke Hu, Yi-Jia Zhang, Jing Han, Jin Chen, Bulubu, Boling Dong, Hao-Zhe Shi, Su-Mei He, Ting-Ting Yu, Xiao Chen, & Dong-Dong Wang. (2024). Drug-drug interaction and initial dosage optimization of aripiprazole in patients with schizophrenia based on population pharmacokinetics. Frontiers in Psychiatry, 1–10. https://doi.org/10.3389/fpsyt.2024.1377268

Chicago

Cun Zhang, Lei Jiang, Ke Hu, Yi-Jia Zhang, Jing Han, Jin Chen, Bulubu, et al. 2024. “Drug-Drug Interaction and Initial Dosage Optimization of Aripiprazole in Patients with Schizophrenia Based on Population Pharmacokinetics.” Frontiers in Psychiatry, July, 1–10. doi:10.3389/fpsyt.2024.1377268.